Weiwei Zheng

机构：Nanjing University of Chinese Medicine

发表论文 4 篇 · 总被引 101 次 · h-index 4

代表论文

• A biomimetic liver cancer on-a-chip reveals a critical role of LIPOCALIN-2 in promoting hepatocellular carcinoma progression (2023 · Acta Pharmaceutica Sinica B · 被引 41)
• Metronomic paclitaxel improves the efficacy of PD-1 monoclonal antibodies in breast cancer by transforming the tumor immune microenvironment. (2020 · PubMed · 被引 41)
• Ultrasound-guided totally implantable venous access ports via the right innominate vein: a new approach for patients with breast cancer (2019 · World Journal of Surgical Oncology · 被引 12)
• Ultrasound‐guided totally implantable venous access device through the right innominate vein in older patients is safe and reliable (2019 · Geriatrics and gerontology international/Geriatrics & gerontology international · 被引 7)